{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:27:22Z","timestamp":1790256442345,"version":"4.1.0"},"reference-count":38,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"14","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-CA151652"],"award-info":[{"award-number":["U54-CA151652"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["126601-MRSG-14-215-01-TBG"],"award-info":[{"award-number":["126601-MRSG-14-215-01-TBG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA178748"],"award-info":[{"award-number":["R01CA178748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2020,4,3]]},"abstract":"<jats:p>Dual pretargeting with anti-CD20 and anti\u2013HLA-DR allows effective therapeutic delivery of a BEZ235 nanoformulation to NHL cells.<\/jats:p>","DOI":"10.1126\/sciadv.aaz9798","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:10:50Z","timestamp":1585768250000},"source":"Crossref","is-referenced-by-count":54,"title":["Pretargeted delivery of PI3K\/mTOR small-molecule inhibitor\u2013loaded nanoparticles for treatment of non-Hodgkin\u2019s lymphoma"],"prefix":"10.1126","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-0479","authenticated-orcid":true,"given":"Kin Man","family":"Au","sequence":"first","affiliation":[{"name":"Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA."},{"name":"Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Z.","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA."},{"name":"Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5674-6408","authenticated-orcid":true,"given":"Steven I.","family":"Park","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA."},{"name":"Levine Cancer Institute, Atrium Health, Division of Hematology and Oncology, 1021 Morehead Medical Dr, Suite 20121, Charlotte, NC 28025, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.366"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246"},{"key":"e_1_3_2_5_2","first-page":"611","article-title":"Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression","volume":"5","author":"Davis T. A.","year":"1999","unstructured":"T. A. Davis, D. K. Czerwinski, R. Levy, Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression. Clin. Cancer Res. 5, 611\u2013615 (1999).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50025"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2825"},{"key":"e_1_3_2_8_2","first-page":"143","article-title":"Anti-CD19 monoclonal antibodies: A new approach to lymphoma therapy","volume":"4","author":"Naddafi F.","year":"2015","unstructured":"F. Naddafi, F. Davami, Anti-CD19 monoclonal antibodies: A new approach to lymphoma therapy. Int. J. Mol. Cell Med. 4, 143\u2013151 (2015).","journal-title":"Int. J. Mol. Cell Med."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0294"},{"key":"e_1_3_2_10_2","first-page":"830","article-title":"Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential","volume":"47","author":"Epstein A. L.","year":"1987","unstructured":"A. L. Epstein, R. J. Marder, J. N. Winter, E. Stathopoulos, F. M. Chen, J. W. Parker, C. R. Taylor, Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Cancer Res. 47, 830\u2013840 (1987).","journal-title":"Cancer Res."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2013.33.e108"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.435"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0483"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1417"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2010.148"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b08122"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-362624"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.09.001"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1482273"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.01.007"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx392"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399408000586"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13065"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/947858"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200725"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-630947"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0017"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025132"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.01.024"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-017-0482-9"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.10.032"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2018.1444683"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315226"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01476"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1039\/C5CS00784D"},{"key":"e_1_3_2_36_2","first-page":"54","article-title":"A pretargeting system for tumor PET imaging and radioimmunotherapy","volume":"6","author":"Kraeber-Bod\u00e9r\u00e9 F.","year":"2015","unstructured":"F. Kraeber-Bod\u00e9r\u00e9, C. Rousseau, C. Bodet-Milin, E. Frampas, A. Faivre-Chauvet, A. Rauscher, R. M. Sharkey, D. M. Goldenberg, J.-F. Chatal, J. Barbet, A pretargeting system for tumor PET imaging and radioimmunotherapy. Front. Pharmacol. 6, 54 (2015).","journal-title":"Front. Pharmacol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1004-0007"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b01383"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-187401"}],"updated-by":[{"DOI":"10.1126\/sciadv.adv0642","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000}}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aaz9798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T13:59:44Z","timestamp":1734703184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aaz9798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":38,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,4,3]]}},"alternative-id":["10.1126\/sciadv.aaz9798"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aaz9798","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"article-number":"eaaz9798"}}